Features & Benefits
Features & Benefits of Regenafil®
Features and Benefits
Inert Biological Carrier Matrix
- Thermoplastic. Formable into any shape at 45°C
- A resilient solid at body temperature
- Insoluble in aqueous fluids at 39°C
- Inert biological carrier used in surgery since 19521
Demineralized Bone Matrix (DBM)
- Also known as demineralized freeze-dried bone allograft (DFDBA)
- Optimal concentration of DBM for osteoinductivity1
- Donor osteoinductivity verified 100%*
- Osteogenic property of demineralized bone matrix was first demonstrated in 19652
- Room Temperature Regenafil contains 60% DBM by weight
Critical Components
By optimizing the concentration of osteoinductive* demineralized bone matrix (DBM), Regenaform and Regenafil provide the foundation for bone regeneration.3 The inert biological carrier matrix allows revascularization to occur, making it an ideal carrier for DBM.4
Clinical Use
These grafts have been used in the following procedures:
Intrabony defects; Periodontal defects; Sinus elevation; Socket/ridge preservation or any contained defect; In conjunction with dental implant placement.
References
1. Wironen J.F. et al., Effect of bone protein and carrier matrices on BMPstimulated osteogenesis. Transactions of the 44th Annual Meeting. Orthopaedic Research Society, 23:2, p. 603, 1998.
2. Urist M.R., Bone: Formation by Autoinduction. Science, 1965. 150(3698): pp. 893-899.
3. Goldberg V., et al., Biology of autografts and allografts. In Bone and Cartilage Allografts: Biology and Clinical Applications. Edited by V. Goldberg and G. Friedlaender. Park Ridge, IL, American Academy of Orthopaedic Surgeons, 1989, p. 3.
4. Gellad FE, Sadato N, Numaguchi Y, Levine AM. Vascular metastatic lesions of the spine: pre-operative embolization. Radiology. 176: 683-6, 1990.
Additional Reading
King C., et al., Effectiveness of Regenafil in Treating Intrabony Pockets–6 Month Results. IADR, March 2002.
*Finished product induced bone formation when implanted in a modified athymic nude rat assay. Findings from an animal model are not necessarily predictive of human clinical results.

